Literature DB >> 11048997

Combined pancreas and kidney transplantation improves survival in patients with end-stage diabetic nephropathy.

G Tydén1, J Tollemar, J Bolinder.   

Abstract

The purpose of this study was to find out whether prolonged normoglycemia, as achieved by a successful pancreas transplantation, can improve survival in patients with insulin-dependent diabetes mellitus. A retrospective analysis of actual 10-yr patient survival rates was done for all renal graft recipients who were given transplants more than 10 yr ago but within the cyclosporin era (i.e. 1981-1988). The actual 10-yr patient survival rate in non-diabetic renal graft recipients was 72%, In recipients of pancreas and kidney grafts and with prolonged function of the pancreas graft, the survival rate was 60%, whereas in patients subjected to simultaneous pancreas and kidney transplantation, but where the pancreatic grafts failed within 2 yr, the survival rate was 33%. In diabetic recipients of kidney transplants alone, the survival rate was 37%. The patient survival rate was substantially higher in non-diabetic patients and patients with functioning pancreas grafts compared with diabetic patients with kidney transplants alone or with failed pancreas grafts. We speculate that the decrease in mortality was due to the beneficial effect of long-term normoglycemia on diabetic late complications.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11048997     DOI: 10.1034/j.1399-0012.2000.140510.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  5 in total

Review 1.  Transplantation of the pancreas.

Authors:  Ugo Boggi; Fabio Vistoli; Francesca Maria Egidi; Piero Marchetti; Nelide De Lio; Vittorio Perrone; Fabio Caniglia; Stefano Signori; Massimiliano Barsotti; Matteo Bernini; Margherita Occhipinti; Daniele Focosi; Gabriella Amorese
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

2.  Improved patient survival with simultaneous pancreas and kidney transplantation in recipients with diabetic end-stage renal disease.

Authors:  J P Lindahl; A Hartmann; R Horneland; H Holdaas; A V Reisæter; K Midtvedt; T Leivestad; O Oyen; T Jenssen
Journal:  Diabetologia       Date:  2013-04-03       Impact factor: 10.122

Review 3.  [Organ transplantation in endocrinology. Islet cells and pancreas].

Authors:  E Jaeckel; T Becker; M P Manns
Journal:  Internist (Berl)       Date:  2004-11       Impact factor: 0.743

4.  Daily use of a muscle pump activator device reduces duration of hospitalization and improves early graft outcomes post-kidney transplantation: A randomized controlled trial.

Authors:  Wen Xie; Max A Levine; Shahid Aquil; Katharine Pacoli; Rafid Al-Ogaili; Patrick P Luke; Alp Sener
Journal:  Can Urol Assoc J       Date:  2021-02       Impact factor: 1.862

Review 5.  [Pancreas and islet transplantation].

Authors:  E Jaeckel; F Lehner
Journal:  Internist (Berl)       Date:  2009-05       Impact factor: 0.743

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.